Proteomics reveals three molecular subtypes of Alzheimer's disease with distinct progression patterns

These findings demonstrate robust, biologically distinct AD subtypes linked to divergent molecular pathways, clinical features, and progression rates. Such refined stratification supports precision diagnostics and targeted therapeutic strategies.